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ABSTRACT
Objective Understanding the causes of death is key to
tackling the burden of three million annual neonatal
deaths. Resource-poor settings lack effective vital
registration systems for births, deaths and causes of
death. We set out to describe cause-speciﬁc neonatal
mortality in rural areas of Malawi, Bangladesh, Nepal
and rural and urban India using verbal autopsy (VA)
data.
Design We prospectively recorded births, neonatal
deaths and stillbirths in seven population surveillance
sites. VAs were carried out to ascertain cause of death.
We applied descriptive epidemiological techniques and
the InterVA method to characterise the burden, timing
and causes of neonatal mortality at each site.
Results Analysis included 3772 neonatal deaths and
3256 stillbirths. Between 63% and 82% of neonatal
deaths occurred in the ﬁrst week of life, and males were
more likely to die than females. Prematurity, birth
asphyxia and infections accounted for most neonatal
deaths, but important subnational and regional
differences were observed. More than one-third of
deaths in urban India were attributed to asphyxia,
making it the leading cause of death in this setting.
Conclusions Population-based VA methods can ﬁll
information gaps on the burden and causes of neonatal
mortality in resource-poor and data-poor settings. Local
data should be used to inform and monitor the
implementation of interventions to improve newborn
health. High rates of home births demand a particular
focus on community interventions to improve hygienic
delivery and essential newborn care.
INTRODUCTION
Each year, approximately three million children die
in the ﬁrst 28 days after birth, predominantly due
to complications of preterm birth, asphyxia and
sepsis.1–3 With postneonatal mortality declining
faster than neonatal mortality,4 these deaths
account for a growing proportion of under-ﬁve
deaths. Understanding the numbers and causes of
neonatal deaths, as well as gender differences and
national and subnational variation, is key to realis-
ing the Every Newborn Action Plan and
post-Millennium Development Goals of a ‘grand
convergence’ in health, with substantial reductions
in neonatal and child mortality.5–8 Unfortunately,
the resource-poor settings that bear the burden of
more than 98% of neonatal deaths often lack the
effective vital registration systems crucial to under-
standing mortality and planning services or
interventions.
Advances in epidemiological modelling methods
have recently been applied to pooled datasets to
characterise neonatal mortality.5 9 Such estimates
are useful at a global level, but have limitations.
Broad underlying assumptions, lack of transparency
in the data and methods used and restrictions on
disaggregating the data limit their relevance at sub-
national levels, where there can be substantial vari-
ation in rates, trends and cause distributions. There
is a growing recognition that measurement rather
than modelling is needed10 11 and frustration at
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What is already known on this topic?
▸ Globally, there are three million neonatal
deaths every year, mostly from prematurity,
asphyxia and sepsis.
▸ Ninety-eight per cent of these deaths occur in
low-income countries, where poor mortality
data hinders intervention strategies.
▸ More direct measurement could guide policy
and practice at national and subnational levels.
What this study adds?
▸ Population-based verbal autopsy (VA) tools
such as InterVA offer a standardised method to
directly measure the burden and causes of
neonatal mortality in low-income settings.
▸ Although patterns of neonatal death differ
between sites, both early and late neonatal
mortality remain unacceptably high.
▸ Localised, direct measurement reveals
important subnational variations in mortality
rates and causes, which might be masked by
estimation methods at the national level.
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unsatisfactory progress with civil registration systems. Global
bodies, including the WHO, call for the application of
ﬁt-for-purpose methods for registering deaths and assigning
their causes in a consistent, systematic and timely manner.12–16
Since 2001, we have implemented community-based surveil-
lance of perinatal events along with verbal autopsies (VA) in
rural Nepal, Bangladesh, Malawi and urban and rural India.
This has enabled us to prospectively document births, neonatal
deaths and their causes within geographical areas covering a
total population of approximately 2.4 million. Using these data,
we describe the rates, timing and causes of neonatal mortality
for 3772 deaths from low-income and middle-income settings,
highlighting regional and gender disparities and identifying
priorities for public health intervention.
METHODS
Study populations
We used data gathered between 2001 and 2011 in cluster rando-
mised controlled trials of community mobilisation ‘women’s
group’ interventions in Bangladesh (Perinatal Care Project
(PCP)17 18), Malawi (MaiMwana19 and MaiKhanda20), India
(Society for Nutrition, Education and Health Action
(SNEHA)21 and Ekjut22) and Nepal (Makwanpur and
Dhanusha23). The data represent 118 084 births recorded in
seven locations with community-based surveillance of perinatal
events. Characteristics of each study population, study timelines
and basic neonatal health indicators are summarised in table 1.
Given the documented effect of the women’s group intervention
on neonatal mortality,24 only data from counterfactual clusters
without women’s groups were included in the analysis.
Counterfactual clusters were not pure control areas in every
setting: in MaiMwana, Malawi, a breastfeeding counselling
intervention was implemented and tested in 12 of the 24 coun-
terfactual clusters;19 in PCP, Bangladesh, four of the nine clus-
ters received training of traditional birth attendants on
resuscitation;25 in Dhanusha, Nepal, a community-based neo-
natal sepsis management intervention was implemented in 9 of
the 30 counterfactual clusters.26
Community-based surveillance and verbal autopsy
Surveillance systems for births and newborn deaths were estab-
lished in each setting. Their design and implementation have
been described elsewhere.17 20 21 23 26–30 Field-based key infor-
mants recruited in cluster subareas identiﬁed births and deaths,
which were then veriﬁed by trained interviewers. At all sites,
stillbirths were distinguished from very early neonatal deaths
based on the absence of signs of life (movement, breathing,
crying) when the infant was born, according to the mother or
other caregivers. In MaiKhanda, Malawi, a simple algorithm
was used to classify deaths as stillbirths or neonatal deaths from
data pertaining to these reported signs of life.30
To ascertain likely causes of neonatal deaths, trained lay inter-
viewers conducted VAs. VA is the process of interviewing a care-
giver, relative or witness to ascertain the presence, absence or
nature of signs, symptoms and circumstances observed at or
around the time of death.31 Interviewers used a structured ques-
tionnaire to gather VA information, usually from the mother of
the deceased child. Questionnaires comprised a series of
ﬁxed-response questions, with space to record open-ended com-
ments, but this open-ended information was not included in the
current analysis, as previous work has shown that it does not
add to biomedical interpretations of cause of death using auto-
mated methods.32 The questionnaires were similar in all settings
(see online supplementary table S1), and interviewers were
trained to ask all relevant questions on the VA questionnaire,
adhering to predeﬁned skip patterns, regardless of perceived
relevance to the speciﬁc case. Interviews were conducted after a
culturally appropriate mourning period. Only VAs with sex and
age at death data were considered to be complete and included
in the study. The VA completion rates for each site are sum-
marised in table 1.
Data management and quality control
Registered vital events identiﬁed by incentivised key informants
or salaried enumerators were conﬁrmed by interviewer visits to
households and, in a subsample of cases, through ﬁeld super-
visor visits. Trends were compared with local public system
registration ﬁgures. Further quality checks during in-country
electronic data entry mandated referral back to the ﬁeld for cor-
rection when errors were detected.17–23 26–30
Interpreting verbal autopsy
VA data were interpreted through InterVA V.4.02 (http://www.
interva.net), an automated method for interpreting signs, symp-
toms and circumstances.33 Based on the reported presence or
absence of indicators, Bayesian reasoning is applied to calculate
the likelihood of 60 possible cause-of-death categories compat-
ible with the International Classiﬁcation of Diseases V.10.
Following procedures outlined in the InterVA user guide,34 vari-
ables describing speciﬁc signs and symptoms were mapped to
equivalent InterVA indicators to generate ﬁles to be processed
through the Bayesian model. For example, any positive
responses to questions about intermittent or fast breathing,
chest in-drawing, grunting or nasal ﬂaring before death were
used to generate a positive response in InterVA’s ‘difﬁculty
breathing’ indicator. One member of the research team (EF)
reviewed the mapping between each study site’s data and the
InterVA input ﬁle as a quality control measure to check plausi-
bility of symptom frequencies.
InterVA requires population HIV and malaria prevalence to be
speciﬁed so that the model can account for baseline differences
between locations. Previous research has shown that simple
descriptions of ‘very low’, ‘low’ or ‘high’ prevalence, corre-
sponding to increasing orders of magnitude, are adequate for
this.35 Malaria and HIV settings for each site are summarised in
table 1.
InterVA reports the probability of up to three of the most
likely causes for each death.33 We summed the likelihoods of
each cause from every individual death to estimate the burden
of each at population level. Dividing this estimate by the total
number of deaths provided population cause-speciﬁc mortality
fractions (CSMFs), and dividing by the number of live births at
each study site provided estimates of cause-speciﬁc mortality
rates (CSMRs). In MaiMwana (Malawi) and all Asian sites, it
was possible to calculate mortality rates by sex, based on the dir-
ectly measured number of liveborn males and females. In
MaiKhanda (Malawi), however, sex was not recorded for all live
births, and estimates of the numbers of liveborn males and
females were derived by splitting the total number on the basis
of the 2010 Demographic and Health Survey live-birth sex ratio
for 2007–2010.36
Ethical considerations
The trials in which the current data were gathered were
approved by either the University College London or the Great
Ormond Street Hospital Research Ethics Committee in the UK,
and by ethical review committees in each setting: the Ethical
Review Committee of the Diabetic Association of Bangladesh,
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the Nepal Health Research Council (with a Memorandum of
Understanding with the Government of Nepal Ministry of
Health), the Independent Ethics Committee for Research on
Human Subjects (Mumbai), an independent ethical committee
in Jamshedpur, India, and the Malawi National Health Sciences
Research Committee.
RESULTS
A total of 3772 neonatal deaths with complete age and sex data
were included in the analysis. The average time from death to
VA interview varied between study sites, with an average of
3 weeks at Ekjut and SNEHA (India), 5–6 weeks at PCP
(Bangladesh) and Dhanusha (Nepal), 29 weeks at MaiMwana
and 67 weeks at MaiKhanda (Malawi). The relatively long
death-to-interview time in MaiKhanda reﬂects the fact that a
large number of VAs were not completed initially, but rather
included as part of a veriﬁcation exercise after the trial ended in
May 2011.30 Interview dates were not available for Makwanpur
(Nepal). The average number of VA indicators per case was
12 for MaiKhanda, 13 for Makwanpur, 14 for Dhanusha, Ekjut
and MaiMwana, 15 for SNEHA and 17 for PCP. Numbers of
stillbirths and neonatal deaths contributed by each study site are
presented in table 2, which also shows crude and sex-speciﬁc
mortality rates and mortality rate ratios comparing males with
females.
Table 3 shows sex-speciﬁc and cause-speciﬁc neonatal mortal-
ity fractions for all InterVA-derived cause categories. Infectious
causes—diarrhoeal disease, meningitis and encephalitis, pneu-
monia and sepsis—were consolidated into a broad cause cat-
egory of infection, and the categories ‘other and unspeciﬁed’
and ‘indeterminate’ were consolidated to facilitate presentation
of cause-speciﬁc rates and overall fractions in ﬁgure 1.
Crude sex-speciﬁc neonatal mortality rates and rate ratios
(table 2) show that males had 20%–50% higher mortality than
females, with rate ratios (95% CIs) ranging from 1.2 (1.0–1.3)
in MaiKhanda to 1.5 (1.1–2.0) in Makwanpur. In most settings,
there were no obvious important differences between cause dis-
tributions by sex (table 3). However, at SNEHA in urban India
and, to a lesser extent, Makwanpur in Nepal, a larger propor-
tion of female deaths were attributed to prematurity.
Figure 2 shows CSMFs by day of death. Across all Asian sites,
approximately one-third of neonatal deaths occurred on the ﬁrst
day of life. This proportion was greater than 40% in both
Malawian sites, and, in all settings, the ﬁrst week of life
accounted for most neonatal deaths, ranging from 63% in
Makwanpur (Nepal) and SNEHA (India) to 82% in MaiKhanda
(Malawi).
DISCUSSION
Using prospective data from seven community-based surveil-
lance systems, we applied an automated method of VA interpret-
ation to provide a uniquely standardised summary and
comparison of neonatal mortality across four low-income and
middle-income settings. Across all settings, and particularly in
rural areas, neonatal mortality rates were unacceptably high and
driven by prematurity, birth asphyxia (intrapartum-related
deaths) and infections, which were particularly important in the
rural Asian sites. The ﬁrst days of life remain the most risky,
with more than one-third of deaths occurring on the ﬁrst day,
half in the ﬁrst 2 days and three-quarters in the ﬁrst week.
Gender disparities
Male gender disadvantage was observed in all study sites, with
boys being up to 50% more likely to die than girls. While our
observation could be a consequence of methodological bias,
whereby social desirability may lead to an over-reporting for
male offspring, a neonatal mortality ratio of males to females of
at least 1.2 has been reported previously.37 38 Recent research
has also shown that boys are more likely to be born prematurely
and have a higher incidence of infections and encephalop-
athy.39–41 With the exception of Dhanusha (Nepal) and PCP
(Bangladesh), sex differentials in CSMFs in table 3 suggested
more infections in males, although prematurity appeared to act
in the opposite direction, and was responsible for a higher pro-
portion of female deaths. Similar ﬁndings for late neonatal
deaths have been observed in other studies from Nepal38 and
India,42 and may reﬂect overarching gender preference or pref-
erential care-seeking as well as interactions between ethnicity,
sex and the presence of prior siblings. The extent to which
observed sex differentials reﬂect biological phenomena or are a
consequence of modiﬁable socioeconomic factors demands
further investigation.
Differences between countries
There were important differences in overall mortality and cause
distributions between settings. PCP (Bangladesh) and the sites in
Malawi and Nepal had similar overall neonatal mortality rates
of 25–35 deaths per 1000 live births. However, the proportion
of deaths attributed to prematurity, birth asphyxia and infections
varied considerably between settings. In the Bangladesh site and
both Nepal sites, the burden of the combined infectious causes
of death accounted for almost two-ﬁfths of the total mortality
burden, whereas in Malawi, the burden ranged from 26% to
34%, and a greater proportion of prematurity-related mortality
was observed. This is perhaps unsurprising given that Malawi is
reported to have the highest prematurity rate in the world, at
18%.43
Differences within countries
Ekjut, in rural India, had the highest neonatal mortality rate of
59 deaths per 1000 live births, almost seven times greater than
SNEHA in urban Mumbai, reﬂecting huge subnational variation.
Infections and prematurity each accounted for around one-third
of neonatal deaths in Ekjut. While infections and prematurity
remained in the top three causes in Mumbai, more than
one-third of deaths were attributed to asphyxia, making it the
leading cause of death. This is in agreement with a neonatal VA
study from the same setting, which identiﬁed one-third of
asphyxia deaths as being associated with obstetric complica-
tions.44 Observed differences between rural and urban India are
likely to reﬂect documented shifts in cause patterns as overall
mortality rates fall, largely driven by decreases in the rates of
death from infections, particularly pneumonia.45
Within-country differences were also observed in Malawi and
Nepal, but are not easily explained by underlying mortality
rates. In Malawi, data from MaiMwana suggest that approxi-
mately one-third of neonatal deaths were attributable to neo-
natal pneumonia/sepsis, approximately 8% greater than the
burden identiﬁed at the MaiKhanda site, where slightly higher
burdens of prematurity and asphyxia were observed. Both
MaiMwana and MaiKhanda represent rural Malawian popula-
tions, but at slightly different times and within a period of rapid
increase in institutional deliveries.36 More births occurred in
facilities in MaiKhanda than in MaiMwana (table 1). Given that
home deliveries are associated with less hygienic practices and
higher rates of infectious causes of neonatal death,46 the higher
proportion of institutional delivery in MaiKhanda may partly
explain the differences in cause-speciﬁc mortality. A similar
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Table 1 Study populations in descending order of neonatal mortality rate
InterVA disease
prevalence
settings
Study site and area description Cluster definition Clusters included
Period of mortality
surveillance
VA completion rate
as proportion of
recorded neonatal
deaths (reference)
Estimated %
institutional births
during data collection Malaria HIV
Ekjut—rural India: three rural districts in Jharkhand
(Saraikela Kharsawan, West Singhbhum) and Odisha
(Keonjhar)22
8–10 villages with residents classified as tribal/
scheduled caste or other backward caste: average
population 6338
18 Aug 2005–Jul 2008 98%22 20%22 High Very
low
SNEHA—urban India: six municipal wards in Mumbai21 Slum area: population ∼1000 residents 24 Oct 2005–Feb 2010 60%44 87%21 Low Very
low
Dhanusha—rural Nepal: district excluding Janakpur
municipality26
Village development committee: population ∼8000 30 Jun 2006–Apr 2011 70% (51) 26%63 Very
low
Very
low
Makwanpur—rural Nepal: village development committee
areas in Makwanpur district23
Village development committee: population ∼7000 12 Apr 2001–Oct 2008 98%* 2%23 Very
low
Very
low
(PCP—rural Bangladesh: nine unions in three rural districts
(Bogra, Faridpur and Moulavibazar)17 18
Union (lowest administrative unit): population 25 000–
30 000
9 Nov 2004–Jul 2011 83%17 18 16%–28%17 18 Very
low
Very
low
MaiMwana—rural Malawi: Mchinji district19 29 Census enumeration area: population ∼3000 24 Jun 2004–Jan 2011 92%* 37%–44%19 High High
MaiKhanda—rural Malawi: three districts in central region
(Kasungu, Lilongwe and Salima)20
Health centre catchment area: population ∼30 000 31 (sample of 4000
from each cluster)
Jun 2007–Dec 2010 86%30 50%–67%20 High High
*Estimated from available data.
PCP, Perinatal Care Project; SNEHA, Society for Nutrition, Education and Health Action; VA, verbal autopsies.
Table 2 Neonatal verbal autopsies (VA) included in the study
Neonatal mortality rate (per 1000 live
births)
Study site
Live births
included
Stillbirths included
(proportion of all deaths)
Neonatal deaths included
(proportion of all deaths) Total Male Female
Crude neonatal mortality
rate ratio (male: female) (95% CI)
Ekjut, rural India 8819 270 (34%) 518 (66%) 59 68 50 1.4 (1.1 to 1.6)
SNEHA, urban India 10 029 80 (48%) 87 (52%) 9 10 7 1.3 (0.8 to 2.1)
Dhanusha, Nepal 15 299* 463 (47%) 528 (53%) 35 39 30 1.3 (1.1 to 1.5)
Makwanpur, Nepal 6735 146 (42%) 203 (58%) 30 36 24 1.5 (1.1 to 2.0)
PCP, rural Bangladesh 42 241 1361 (51%) 1324 (49%) 31 36 27 1.3 (1.2 to 1.5)
MaiMwana, Malawi 15 258 324 (46%) 382 (54%) 25 29 21 1.4 (1.1 to 1.7)
MaiKhanda, Malawi 22 563* 612 (46%) 730 (54%) 32 35 30 1.2 (1.0 to 1.4)
*Estimated from available data.
PCP, Perinatal Care Project; SNEHA, Society for Nutrition, Education and Health Action.
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scenario may also explain differences observed between
Makwanpur (2% facility deliveries) and Dhanusha (26% facility
deliveries) in Nepal. However, the different time periods for
data collection and contextual differences between the plains of
Dhanusha and the hills of Makwanpur may also be important.
Finally, the substantial difference in the proportion of deaths
with insufﬁcient VA data to attribute a speciﬁed cause (cate-
gorised as ‘indeterminate’ and ‘other unspeciﬁed’ in table 3)
suggests that observed differences in cause distribution may also
relate to underlying differences in VA data completeness.
Study strengths and limitations
The prospective birth and death surveillance systems, high
follow-up rate for completion of VAs, data quality procedures
and large sample size are the strengths of the study. There
remains a potential bias if certain neonatal deaths were systemat-
ically unsuccessfully followed up for VA, but we do not expect
this given that the sum of the VA-derived CSMRs closely
approximated total mortality rates derived from surveillance in
the same areas.17–23 The use of InterVA is also a strength in that
it allows identiﬁcation of multiple causes of death per case with
quantiﬁed degrees of certainty, provides conﬁdence that
observed differences are not a consequence of differing methods
of assigning causes and has been shown to compare well with
available reference standards for cause of death in a range of set-
tings,47 including perinatal death classiﬁcations.48 Indeed, the
CSMFs identiﬁed by InterVA for Dhanusha and SNEHA were
similar to those derived by physician review.44 49 Cause distribu-
tions were also similar between InterVA and physician interpret-
ation of neonatal VA data from Ekjut and PCP (unpublished
data). However, physicians at PCP identiﬁed asphyxia as the
leading cause of death, and Ekjut physicians attributed a sub-
stantial number of neonatal deaths to hypothermia, which is not
one of the causes included in the 2012 WHO VA standards and,
therefore, in InterVA, which may have largely classiﬁed such
deaths as ‘indeterminate’.
Several methodological limitations might have inﬂuenced the
cause distributions observed. The speciﬁc questionnaires used at
each site, though similar, were not exactly the same, and the
period between neonatal death and VA interview differed. In
addition to the potential biases inherent in survey methods and
maternal reporting,50 51 these differences may have inﬂuenced
VA respondents’ ability to recognise, recall and report signs and
symptoms. They may also partly explain the differing mean
number of non-missing indicators reported per case in each
setting, ranging from 12 in MaiKhanda to 17 in Bangladesh.
Similarly, it is possible that the processing of common questions
into site-speciﬁc translations for InterVA may have led to subtle
differences in meaning and comprehension. Although there is no
empirical evidence on the effect of such factors on VA-derived
causes of death, and InterVAwas designed with the reality of dif-
ferent VA data collection tools in mind (eg, only afﬁrmative
reports of the presence of indicators inﬂuence cause probabil-
ities), the possibility that differing cause distributions are driven
by differing data capture methods cannot be ruled out.
Comparisons with other studies
In general, our analysis supports current modelled characterisa-
tions of neonatal mortality at an aggregate level.45 Our cause-
distribution ﬁndings are also similar in magnitude and rank
order to survey results reported elsewhere for comparable set-
tings,44 49 52 53 and are broadly similar to descriptions of neo-
natal mortality from 18 INDEPTH health and demographic
surveillance sites using similar methods.54 There are some
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notable exceptions. Chowdhury et al55 identiﬁed birth asphyxia
as the leading cause among 365 neonatal deaths in Matlab, rural
Bangladesh, accounting for 45% of the total burden, whereas
infection-related causes accounted for less than 20% of deaths.
This contrasts with our ﬁndings from Bangladesh, which attribu-
ted approximately one-quarter of deaths to asphyxia and a
much higher proportion to infections. Conversely, comparisons
of our ﬁndings with public domain INDEPTH data56 for 1619
and 207 neonatal deaths from Bangladesh and India, respect-
ively, identify higher CSMFs of asphyxia and lower proportions
of other unspeciﬁed/indeterminate causes in our data. While it
is possible that such differences reﬂect varying epidemiology
and rates of skilled attendance at birth between different areas,
it is also conceivable that they are an artefact of differing VA
survey methods. The Matlab study, for example, had a relatively
small sample size, and VA interpretation was by a panel of physi-
cians required to reach consensus on a single cause of death for
each case.55 Neonatal causes of death can be difﬁcult to attri-
bute with certainty, depending on clinical factors and issues of
deﬁnition; a recent analysis showed a ﬁvefold difference in the
proportion of deaths attributed to prematurity depending on
deﬁnition used.57 As such, identifying a single direct cause of
death from VA may be unrealistic and masks the uncertainty
that may have been evident in the original physicians’ consider-
ation of individual cases. Our method, and that used by the
INDEPTH group, of calculating population-level CSMFs and
splitting deaths between multiple causes is arguably a more
epidemiological approach that shifts the focus from individuals
to populations.58 This fundamental methodological difference
may explain the lower overall proportion of asphyxia deaths
observed in the INDEPTH datasets as well as ours compared
with the study by Chowdhury et al.55 Given that both PCP and
the INDEPTH data were interpreted using InterVA V.4.02
however, differences between these datasets must be due to
other reasons, possibly underlying differences in the time and
location of the surveys, or differences in VA data capture.
Programmatic implications
At all study sites, stillbirths accounted for a large proportion of
deaths in the extended perinatal period. The estimates in our
data ranged from 34% in Ekjut, India, to 51% in PCP,
Bangladesh. All methods used to distinguish stillbirths from
early neonatal deaths are open to misclassiﬁcation bias, inﬂu-
enced by sociocultural factors and limited assessment of vital
signs or attempts at resuscitation in apparently lifeless newborns,
particularly after home birth.59 Misclassiﬁcation bias notwith-
standing, the burden of stillbirths remains high and is likely to
reﬂect inadequacies in skilled attendance at birth and the avail-
ability of emergency obstetric care and caesarean sections.
The neonatal cause-of-death distributions described here have
important programmatic implications. High levels of infection
and prematurity-related deaths imply that essentials of hygienic
delivery and newborn care, including thermal care, remain pri-
orities. Preventative strategies that target maternal health,
Figure 1 Total and cause-speciﬁc neonatal mortality rates by study site ordered left to right by decreasing neonatal mortality rate. Superimposed
numbers represent cause-speciﬁc mortality fractions (CSMFs) (%) for each site.
PCP, Perinatal Care Project; SNEHA, Society for Nutrition, Education and Health Action.
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recognising the importance of nutrition and vector-borne dis-
eases such as malaria, a major cause of anaemia in malaria
endemic regions, must also be prioritised. At the same time, the
major burden of asphyxia mortality demands a focus on the
intrapartum period, with improved capacity within facilities to
manage obstetric complications and awareness of the import-
ance of skilled attendance at birth among communities and
expectant mothers. Given the high rates of home births, inter-
vention strategies must think beyond the biomedical aspects of
mortality described by VA results and consider the distal, social
determinants of mortality and the three delays model.60 In this
regard, there is a clear need to focus on community
interventions for newborn health that also encompass the health
of the mother and the continuum of preconception, pregnancy
and the intrapartum and postpartum periods, and which
promote hygienic practices, thermal care, the recognition of
danger signs and appropriate care-seeking. There is a growing
body of evidence suggesting that cost-effective community inter-
ventions achieving impact on neonatal mortality should be
scaled up as a matter of urgency.24 61 62
CONCLUSION
The application of simple mortality surveillance and VA
methods in localised, low-income and middle-income settings
Figure 2 Cause-speciﬁc mortality fractions (CSMFs) by day of death and study site ordered left to right by decreasing neonatal mortality rate.
PCP, Perinatal Care Project; SNEHA, Society for Nutrition, Education and Health Action.
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reveals important regional and subnational variation in the epi-
demiology of neonatal mortality that may be masked by aggre-
gate or modelled estimates. Although population health survey
and VA approaches are likely to be imperfect compared with
complete vital registration and medical cause of death certiﬁca-
tion, methodological advances enable the generation of timely,
low-cost and consistent cause-speciﬁc mortality estimates neces-
sary to direct local policy in settings with little or no existing
data. The wider application of these methods beyond research
settings to better inform and strengthen health systems is a
global priority. However, it is not for lack of data that the
burden of neonatal mortality remains so high; efforts must
focus on implementing proven interventions to protect the three
million newborns who die every year.
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